Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Research a New Predictive Marker of Intraventricular Hemorrhage in Very Preterm Infants: HEMO PREMA Study

NCT02400853 is registered in ClinicalTrials.gov with University Hospital, Rouen as lead sponsor.

NCT NCT02400853
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02400853 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Research a New Predictive Marker of Intraventricular Hemorrhage in Very Preterm Infants: HEMO PREMA Study
Lead sponsor
University Hospital, Rouen
Phase
Not applicable
Overall status
Completed
Start date
July 10, 2015
Completion date
April 21, 2020
Enrollment
175 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intraventricular hemorrhage